EPISODE · Mar 18, 2025 · 54 MIN
Episode 219: Major Progress in Adjuvant Renal Cell Carcinoma
from Healthcare Unfiltered · host Chadi Nabhan
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease recurrence, as well as the rapid enrollment of this innovative study and what it means for the future of kidney cancer treatment.Read the publication in Nature.https://www.nature.com/articles/s41586-024-08507-5Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
Embed this episode
What this episode covers
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease recurrence, as well as the rapid enrollment of this innovative study and what it means for the future of kidney cancer trea...
NOW PLAYING
Episode 219: Major Progress in Adjuvant Renal Cell Carcinoma
No transcript for this episode yet
Similar Episodes
No similar episodes found.